Nucleic Acid Therapeutics
The CAS Research Focus brings together researchers to discuss the current state of development in the different research branches of nucleic acid-based therapeutics, as well as potential alternatives, and to explore new approaches.
The Corona pandemic has initiated a new phase in the field of vaccine development with the generation of RNA-based vaccines. But not only there: therapeutics developed on the basis of nucleic acids will play an increasingly important role in drug development or therapy in the coming years and change medicine. For untreatable or poorly treatable diseases, the new class of substances will show breakthrough treatment successes.
The CAS Research Focus brings together researchers to discuss the current state of development in the different research branches of nucleic acid-based therapeutics, as well as potential alternatives, and to explore new approaches.
Spokespersons
Working Group
- Prof. Dr. Stefan Engelhardt (Pharmacology and Toxicology, TUM)
- Dr. Pascal Giehr (Chemische Epigenetik)
- Prof. Dr. Sebastian Kobold (CAS Young Center / Clinical Pharmacology)
- Prof. Dr. Joachim Rädler (Softmatter Group)
- Dr. Sabine Schneider (CAS Young Center / Chemisitry)
- Prof. Dr. Ernst Wagner (Pharmazeutische Biotechnologie)
Visiting Fellow
University of Michigan
Visiting Fellow, CAS Research Focus “Nucleic Acid Therapeutics”
Events
-
25 JulNew Frontier in Chemical BiologySymposium of the SFB1309, the C-NATM Cluster and the CAS Research Focus “Nucleic Acid Therapeutics”.
-
10 AprFrom Viruses to Vaccines: Nanopore Studies on Chemically Modified RNA
Speaker: Prof. Cynthia J. Burrows, Ph.D. (University of Utah) | Chair: Dr. Pascal Giehr (LMU)
-
23 JanDeveloping mRNA Based Therapeutics
Referent: Dr. Patrick Baumhof (CureVac, Tübingen) | Moderation: Prof. Dr. Olivia Merkel (LMU)
-
30 NovGene Silencing in HSPCs with an Apolipoprotein A1-Based Nanodelivery Platform
Speaker: Prof. Roy van der Meel, Ph.D. (Eindhoven University of Technology) | Chair: Dr. Sabine Schneider (LMU)
-
19 JulLiving in the World of RNA Therapeutics
Speaker: Dr. Muthiah Manoharan (Alnylam Pharmaceuticals) | Chair: Prof. Dr. Olivia Merkel (LMU)
-
19 JanOn the Development of Personalized Cancer Vaccines Based on HLA Ligandome Analysis
Speaker: Prof. Dr. Hans-Georg Rammensee (Tübingen) | Chair: Prof. Dr. Sebastian Kobold (LMU)
-
24 JunNew RNA Therapeutics
Workshop led by Prof. Dr. Olivia Merkel (CAS Young Center/LMU) and Prof. Dr. Thomas Carell (LMU).
